Gene therapy for uveal melanoma
Clinical and Translational Oncology · 14.07.2026
DOI: 10.1007/s12094-026-04499-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 14.07.2026. Verfasst von Anika Bushra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Uveal melanoma (UM) is one of the most prevalent types of intraocular melanomas, which has relatively high morbidity and mortality rates despite being a rare disease. Genetic modifications are one of the prime driving forces behind cellular growth, proliferation, and migration in UM, among which mutation of driver genes (e.g., GNA11, GNAQ, BAP1, EIF1AX, and SF3B1, etc.) and epigenetic modifications (e.g., DNA methylation, histone modifications, and non-coding RNAs) are the key drivers behind oncogenesis. A feasible treatment approach for UM could be gene therapy targeting these genetic mutations and implicated pathways. In this review, current therapeutic options for the treatment of primary and metastatic UM will be briefly discussed in the context of the major driver gene and epigenetic mutations in UM. Primary focus will be on the current state of RNA interference, non-coding RNA, gene editing, gene replacement, and suicide gene therapies for UM, including prospective targeting strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
- Biomedical Research Center in Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, USA.
- Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. jirudaya@illinois.edu.
- Biomedical Research Center in Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, USA. jirudaya@illinois.edu.
- Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. jirudaya@illinois.edu.
- Carle-Illinois College of Medicine, Champaign, IL, 61820, USA. jirudaya@illinois.edu.
Zitieren
APA
Bushra, A., & Irudayaraj, J. (2026). Gene therapy for uveal melanoma. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04499-y
Vancouver
Bushra A, Irudayaraj J. Gene therapy for uveal melanoma. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04499-y
BibTeX
@article{Bushra2026,
author = {Bushra, Anika and Irudayaraj, Joseph},
title = {Gene therapy for uveal melanoma},
journal = {Clinical and Translational Oncology},
year = {2026},
doi = {10.1007/s12094-026-04499-y}
}
EUVIMED